Topical BioMedics Inc. has introduced a new Topricin floor display for retailers. The company said Wednesday that the four-color unit sports a small footprint yet holds multiple combinations of any Topricin topical pain relief formula and size, providing maximum flexibility, exposure and sales.
Emdeon Inc. has entered into an agreement to acquire Change Healthcare, a provider of health care consumer engagement and transparency solutions Emdeon, a Nashville, Tenn.
Veteran Energizer Holdings Inc. executive Lou Martire plans to retire next year after more than four decades at the company.
Pfizer Inc. has released Trumenba, a meningococcal group B vaccine, to pharmacies and other health care providers in the United States.
Pharmaceutical industry veteran Ernest Sabo plans to retire from Lannett Co. next year. The generic pharmaceutical company said late Monday that Sabo, vice president of regulatory affairs and chief compliance officer, is slated to retire effective Jan. 2, 2015.
Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said Monday that its generic celecoxib product, approved by Health Canada, is available now in pharmacies across Canada.
Cosmetics and beauty care giant Revlon Inc. has relaunched its brand with a global tagline, its first in more than a decade.
Patrick Lockwood-Taylor, vice president of personal health care for North America and digestive wellness design at Procter & Gamble Co., has been elected as chairman of the Consumer Healthcare Products Association (CHPA).
Galderma Laboratories has unveiled a new look for its Cetaphil RestoraDerm line of eczema-soothing products.
Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create one of the top-10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015.
The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as the agency seeks more bioequivalence information.
Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter & Gamble Co. The companies said Thursday that the deal, encompassing roughly $6.
Information and imaging technology giant Xerox is making an investment in telehealth provider HealthSpot Inc.
Kirby Lester reported a spike in sales of its KL1 and KL1Plus tablet counters in October following the Drug Enforcement Agency’s reclassification of hydrocodone combination products to Schedule II. Kirby Lester KL1 (left) and KL1Plus tablet counters.
Aaron Loutsch has been promoted to senior vice president and chief technology officer (CTO).
Eli Lilly and Co. has released Trulicity, a once-weekly treatment for type 2 diabetes, to U.S. pharmacies. Lilly said Monday that Trulicity (dulaglutide) comes in a single-dose pen, in 0.75 mg and 1.5 mg doses, and doesn’t require patients to mix, measure, or handle the needle.
